⌘K

Login Start Free

Home/Filings/4/0001181431-13-040633

4//SEC Filing

Transcept Pharmaceuticals Inc 4

Accession 0001181431-13-040633

CIK 0001178711operating

View on SEC.gov Company Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 6:10 PM ET

Size

5.3 KB

Accession

0001181431-13-040633

Insider Transaction Report

Form 4

Period: 2013-07-15

Transcept Pharmaceuticals IncTSPT

SVP, Chief Business Officer

Transactions

Award
Common Stock Option (right to buy)
2013-07-15+115,000→ 115,000 total
Exercise: $2.93Exp: 2023-07-15→ Common Stock (115,000 underlying)

Footnotes (1)

[F1]The option vests in forty-eight equal monthly installments beginning on August 15, 2013.

Documents

1 file

4
rrd386017.xmlPrimary
FORM 4 - KOLLINS

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001178711

Filing Metadata

Form type: 4
Filed: Jul 17, 8:00 PM ET
Accepted: Jul 18, 6:10 PM ET
Size: 5.3 KB

View on SEC.gov